VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,216,000 | +409.7% | 117,460 | +448.9% | 4.32% | +386.9% |
| Q3 2021 | $631,000 | -44.5% | 21,401 | -36.1% | 0.89% | -56.0% |
| Q2 2021 | $1,137,000 | +1.9% | 33,467 | -2.5% | 2.02% | +24.7% |
| Q1 2021 | $1,116,000 | -4.5% | 34,329 | -14.0% | 1.62% | +23.5% |
| Q4 2019 | $1,168,000 | +46.2% | 39,900 | +33.4% | 1.31% | +106.9% |
| Q3 2019 | $799,000 | -61.6% | 29,900 | -63.2% | 0.63% | -77.7% |
| Q2 2019 | $2,079,000 | -40.8% | 81,350 | -48.1% | 2.84% | +16.0% |
| Q1 2019 | $3,513,000 | +19.4% | 156,683 | +12.3% | 2.45% | -25.6% |
| Q4 2018 | $2,942,000 | -3.9% | 139,495 | -15.6% | 3.29% | +49.4% |
| Q3 2018 | $3,060,000 | +55.5% | 165,204 | +87.3% | 2.20% | +39.5% |
| Q2 2018 | $1,968,000 | -12.4% | 88,204 | -13.7% | 1.58% | -57.5% |
| Q1 2018 | $2,246,000 | +0.6% | 102,204 | +6.3% | 3.71% | +5.5% |
| Q4 2017 | $2,233,000 | – | 96,103 | – | 3.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |